MTM1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.420230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.455200E-01
Normal-vs-Stage2
1.682590E-01
Normal-vs-Stage3
8.004000E-02
Normal-vs-Stage4
6.950000E-01
Stage1-vs-Stage2
4.467400E-01
Stage1-vs-Stage3
6.926400E-02
Stage1-vs-Stage4
9.406600E-01
Stage2-vs-Stage3
1.205570E-01
Stage2-vs-Stage4
4.661000E-01
Stage3-vs-Stage4
1.626210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.806400E-02
Normal-vs-AfricanAmerican
6.595000E-01
Normal-vs-Asian
5.773600E-01
Caucasian-vs-AfricanAmerican
1.734180E-01
Caucasian-vs-Asian
5.955400E-01
AfricanAmerican-vs-Asian
7.569400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.224400E-01
Normal-vs-Female
1.912640E-01
Male-vs-Female
5.198000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.583000E-01
Normal-vs-Age(41-60Yrs)
3.933800E-01
Normal-vs-Age(61-80Yrs)
7.699900E-02
Normal-vs-Age(81-100Yrs)
1.829780E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.191600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.558000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.234800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.981700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.709170E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.872800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.888400E-01
Normal-vs-Daily Drinker
5.434300E-02
Normal-vs-Weekly Drinker
1.416220E-01
Normal-vs-Occasional Drinker
2.263000E-01
Normal-vs-Social Drinker
1.739350E-01
Non Drinker-vs-Daily Drinker
1.533960E-01
Non Drinker-vs-Weekly Drinker
2.964400E-01
Non Drinker-vs-Occasional Drinker
9.077800E-01
Non Drinker-vs-Social Drinker
8.901800E-01
Daily Drinker-vs-Weekly Drinker
9.143600E-01
Daily Drinker-vs-Occasional Drinker
1.060810E-01
Daily Drinker-vs-Social Drinker
1.952970E-01
Weekly Drinker-vs-Occasional Drinker
2.331200E-01
Weekly Drinker-vs-Social Drinker
3.494200E-01
Occasional Drinker-vs-Social Drinker
7.797000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.689440E-01
Normal-vs-Grade 2
4.764000E-02
Normal-vs-Grade 3
7.112500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.399240E-01
Grade 1-vs-Grade 3
1.480220E-01
Grade 1-vs-Grade 4
1.689440E-01
Grade 2-vs-Grade 3
7.514800E-01
Grade 2-vs-Grade 4
4.764000E-02
Grade 3-vs-Grade 4
7.112500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.767800E-02
Normal-vs-NonDiabetic
1.045220E-01
Diabetic-vs-NonDiabetic
5.208400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.013200E-01
Normal-vs-NoPancreatitis
8.164300E-02
Pancreatitis-vs-NoPancreatitis
4.686200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.885210E-01
Normal-vs-N1
1.476020E-01
N0-vs-N1
9.077400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.011000E-01
Normal-vs-TP53-NonMutant
3.618800E-01
TP53-Mutant-vs-TP53-NonMutant
8.240800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
